Skip to content

SEGMED: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SEGMED

BE 0871.990.111
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€20,474
2024 · €22,987-€43,461
Equity
€228,054
2024 · €329,828-€101,774
Cash
€89,691
2024 · €258,313-€168,622
Balance sheet total
€228,054
2024 · €349,868-€121,814

Largest movements

2024 to 2025
Assets
  • Cash -€168,622

    down €168,622 (-65.3%), from €258,313 to €89,691

    mainly Contributions, distributions and other (-€81,300) and Receivables within one year (-€35,098)

  • Receivables within one year +€35,098

    up €35,098 (+332%), from €10,565 to €45,663

    of which Other amounts receivable: +€27,658

  • Tangible fixed assets +€13,774

    up €13,774 (+52.0%), from €26,514 to €40,289

    of which Furniture and vehicles: +€7,812

Equity and liabilities
  • Reserves -€101,774

    down €101,774 (-37.4%), from €272,428 to €170,654

    of which Distributable reserves: -€101,774

  • Trade debts -€14,578

    down €14,578 (-100%), from €14,578 to €0

  • Other debts -€3,526

    down €3,526 (-100%), from €3,526 to €0

Income statement
  • Gross operating margin -€67,885

    down €67,885, from €55,709 to -€12,176

  • Other operating charges -€13,918

    down €13,918 (-93.0%), from €14,972 to €1,054

  • Taxes -€9,062

    down €9,062 (-97.1%), from €9,336 to €273

  • Financial income +€2,044

    up €2,044 (+806%), from €254 to €2,297

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €22,987
Gross operating margin -€67,885
Depreciation -€543
Other operating charges +€13,918
Financial income +€2,044
Financial charges -€57
Taxes +€9,062
Result 2025 -€20,474
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€64,658
Investment -€22,663
Financing -€81,300
Cash 2024 €258,313
Net result for the year -€20,474
Depreciation +€8,889
Receivables within one year -€35,098
Deferred charges and accrued income +€2,065
Trade debts -€14,578
Tax, wage and social debts -€1,936
Other debts -€3,526
Investment in fixed assets (net) -€22,663
Contributions, distributions and other -€81,300
Cash 2025 €89,691
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €349,868 €228,054 -€121,814 -34.8%
Fixed assets 21/28 €26,514 €40,289 +€13,774 +52.0%
Tangible fixed assets 22/27 €26,514 €40,289 +€13,774 +52.0%
Plant, machinery and equipment 23 - €2,571 +€2,571
Furniture and vehicles 24 €21,868 €29,680 +€7,812 +35.7%
Other tangible fixed assets 26 €4,646 €8,037 +€3,391 +73.0%
Current assets 29/58 €323,354 €187,765 -€135,589 -41.9%
Amounts receivable within one year 40/41 €10,565 €45,663 +€35,098 +332%
Trade receivables 40 €9,204 €16,644 +€7,440 +80.8%
Other amounts receivable 41 €1,361 €29,019 +€27,658 +2,032%
Current investments 50/53 €50,375 €50,375 = 0.0%
Cash at bank and in hand 54/58 €258,313 €89,691 -€168,622 -65.3%
Deferred charges and accrued income 490/1 €4,101 €2,036 -€2,065 -50.4%
Total equity and liabilities 10/49 €349,868 €228,054 -€121,814 -34.8%
Equity 10/15 €329,828 €228,054 -€101,774 -30.9%
Contributions 10/11 €57,400 €57,400 = 0.0%
Reserves 13 €272,428 €170,654 -€101,774 -37.4%
Non-distributable reserves 130/1 €0 - =
Reserves not available under the articles 1311 €0 - =
Distributable reserves 133 €272,428 €170,654 -€101,774 -37.4%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €20,040 €0 -€20,040 -100%
Amounts payable within one year 42/48 €20,040 €0 -€20,040 -100%
Trade debts 44 €14,578 €0 -€14,578 -100%
Suppliers 440/4 €14,578 €0 -€14,578 -100%
Taxes, remuneration and social security 45 €1,936 €0 -€1,936 -100%
Taxes 450/3 €1,936 €0 -€1,936 -100%
Other amounts payable 47/48 €3,526 €0 -€3,526 -100%
Non-recurring operating income 76A €5,785 €0 -€5,785 -100%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,346 €8,889 +€543 +6.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €0 - =
Other operating charges 640/8 €14,972 €1,054 -€13,918 -93.0%
Gross operating margin 9900 €55,709 -€12,176 -€67,885
Operating profit (loss) 9901 €32,391 -€22,119 -€54,510
Financial income 75/76B €254 €2,297 +€2,044 +806%
Recurring financial income 75 €254 €2,297 +€2,044 +806%
Financial charges 65/66B €322 €379 +€57 +17.5%
Recurring financial charges 65 €322 €379 +€57 +17.5%
Non-recurring financial charges 66B €0 - =
Profit (loss) for the period before taxes 9903 €32,323 -€20,201 -€52,523
Income taxes 67/77 €9,336 €273 -€9,062 -97.1%
Profit (loss) for the period 9904 €22,987 -€20,474 -€43,461
Profit (loss) for the period to be appropriated 9905 €22,987 -€20,474 -€43,461

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.